PharmX Technologies Limited (ASX:PHX)

PharmX Technologies Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	81	56	23	22	20	52
Market Cap Growth	71.17%	144.74%	2.90%	8.94%	-60.92%	199.92%
Enterprise Value	78	51	11	17	14	45
Last Close Price	0.14	0.09	0.04	0.03	0.03	0.07
PE Ratio	-	-	-	-	80.52	47.59
PS Ratio	10.75	7.39	2.81	3.61	3.77	4.37
PB Ratio	5.08	3.50	1.42	1.00	0.87	2.26
P/TBV Ratio	19.56	13.45	7.48	2.50	8.19	14.24
P/FCF Ratio	-	-	7.13	2.04	6.37	18.14
P/OCF Ratio	-	-	7.10	2.02	6.18	16.42
EV/Sales Ratio	10.31	6.82	1.31	2.78	2.65	3.78
EV/EBITDA Ratio	150.20	129.72	19.99	-	21.02	26.90
EV/EBIT Ratio	-	466.97	43.42	-	112.40	36.72
EV/FCF Ratio	-9.52	-	3.32	1.57	4.48	15.67
Debt / Equity Ratio	0.06	0.06	0.02	0.00	0.01	0.01
Debt / EBITDA Ratio	1.73	1.73	0.38	-	0.32	0.15
Debt / FCF Ratio	-	-	0.08	0.00	0.10	0.11
Asset Turnover	0.31	0.31	0.24	0.18	0.17	0.47
Inventory Turnover	-	-	-	-	85.40	173.43
Quick Ratio	3.27	3.27	1.36	1.25	1.64	1.39
Current Ratio	3.33	3.33	1.37	1.84	1.68	1.63
Return on Equity (ROE)	-1.65%	-1.65%	0.50%	-3.89%	-0.57%	5.97%
Return on Assets (ROA)	0.28%	0.28%	0.46%	-1.23%	0.26%	3.02%
Return on Invested Capital (ROIC)	-2.91%	-4.67%	1.84%	-4.89%	-0.79%	6.89%
Return on Capital Employed (ROCE)	0.60%	0.60%	1.40%	-2.70%	0.50%	4.90%
Earnings Yield	-0.33%	-0.47%	-7.78%	-4.75%	1.24%	2.10%
FCF Yield	-10.08%	-14.66%	14.02%	49.13%	15.70%	5.51%
Payout Ratio	-	-	-	-	-	82.13%
Buyback Yield / Dilution	-0.06%	-0.06%	-0.17%	0.56%	-9.81%	-57.55%
Total Shareholder Return	-0.06%	-0.06%	-0.17%	0.56%	-9.81%	-57.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.